EVH
EVH
US30050B1017
Evolent Health, Inc
Loading chart...

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Latest News

Related stocks

PHR
PHR • United States
Phreesia, Inc.
10.81 USD
670.99M USD 1Y -54.2%
TALK
TALK • United States
Talkspace, Inc.
5.25 USD
870.57M USD
OMDA
OMDA • United States
Omada Health, Inc.
21.55 USD
1.32B USD 1Y -13.2%
WEAV
WEAV • United States
Weave Communications, Inc.
7.38 USD
593.72M USD 1Y +7.4%
OMCL
OMCL • United States
Omnicell, Inc.
35.82 USD
1.63B USD 1Y +10.7%
HSTM
HSTM • United States
HealthStream, Inc.
33.13 USD
1.01B USD 1Y +19.5%
CERT
CERT • United States
Certara, Inc.
9.13 USD
1.39B USD 1Y -33.5%
GDRX
GDRX • United States
GoodRx Holdings, Inc.
3.43 USD
1.17B USD 1Y -23.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
63.3% p.a.
Max Drawdown (5Y)
-94.5%
Sharpe Ratio (5Y)
-0.59
Beta Factor
1.02
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 253%.
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (72.2%) is noticeably higher than the 5Y average (63.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (63.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -94.5% in the extended horizon.
ende